• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT C16000 PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT C16000 PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE Back to Search Results
Catalog Number 03L77-01
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/14/2025
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed falsely decreased sodium results for several patients on an architect c16000 analyzer.The following example was provided (customer¿s normal range is 135-145 mmol/l): patient 2 initial result was 115, repeat result, on another analyzer, is 139 mmol/l.There was no impact to patient management reported.
 
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Additional Manufacturer Narrative
An abbott field service representative (fsr) was dispatched due to the customer reporting falsely decreased sodium results on an architect c16000 processing module, serial number (b)(6).Through an extensive investigation, the fsr found the tbg overflow cup-lower wst man (rohs), part number 2-89426-02, needed to be cleaned due to overflowing, which resolved the issue.No subsequent issues have been reported.A review of the instrument history revealed no contributing factors described in this complaint.A review of labeling and historical data was done, and both were adequate, with no increase in complaint activity.Based on all available information and abbott diagnostics' complaint investigation, no systemic issue or product deficiency was identified.
 
Event or Problem Description
The customer observed falsely decreased sodium results for several patients on an architect c16000 analyzer.The following example was provided (customer¿s normal range is 135-145 mmol/l): patient 2 initial result was 115, repeat result, on another analyzer, is 139 mmol/l.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT C16000 PROCESSING MODULE
Common Device Name
ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key22708497
Report Number3016438761-2025-00453
Device Sequence Number21060681
Product Code JJE
UDI-Device Identifier00380740005924
UDI-Public(01)00380740005924
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03L77-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/14/2025
Supplement Date Received by Manufacturer08/11/2025
Initial Report FDA Received Date08/04/2025
Supplement Report FDA Received Date08/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/01/2019
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-